These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

359 related items for PubMed ID: 11583733

  • 21. Disseminated intravascular coagulation at an early phase of trauma is associated with consumption coagulopathy and excessive fibrinolysis both by plasmin and neutrophil elastase.
    Hayakawa M, Sawamura A, Gando S, Kubota N, Uegaki S, Shimojima H, Sugano M, Ieko M.
    Surgery; 2011 Feb; 149(2):221-30. PubMed ID: 20655560
    [Abstract] [Full Text] [Related]

  • 22. Diagnosis of disseminated intravascular coagulation by hemostatic molecular markers.
    Wada H, Gabazza E, Nakasaki T, Shimura M, Hiyoyama K, Deguchi K, Nishikawa M, Sakuragawa N, Shiku H.
    Semin Thromb Hemost; 2000 Feb; 26(1):17-21. PubMed ID: 10805276
    [Abstract] [Full Text] [Related]

  • 23. [Coagulation and fibrinolysis parameters in disseminated intravascular coagulation (DIC)].
    Nakagawa T, Saito H, Watanabe Y, Sato M, Murakawa E.
    Rinsho Byori; 1991 Mar; 39(3):309-14. PubMed ID: 1828842
    [Abstract] [Full Text] [Related]

  • 24. Combination of thrombin-antithrombin complex, plasminogen activator inhibitor-1, and protein C activity for early identification of severe coagulopathy in initial phase of sepsis: a prospective observational study.
    Koyama K, Madoiwa S, Nunomiya S, Koinuma T, Wada M, Sakata A, Ohmori T, Mimuro J, Sakata Y.
    Crit Care; 2014 Jan 13; 18(1):R13. PubMed ID: 24410881
    [Abstract] [Full Text] [Related]

  • 25. Hemostatic molecular markers before onset of disseminated intravascular coagulation in leukemic patients.
    Wada H, Sakuragawa N, Shiku H.
    Semin Thromb Hemost; 1998 Jan 13; 24(3):293-7. PubMed ID: 9701463
    [Abstract] [Full Text] [Related]

  • 26. Diagnosis of pre-disseminated intravascular coagulation stage with hemostatic molecular markers. The Mie DIC Study Group.
    Wada H, Wakita Y, Nakase T, Shimura M, Hiyoyama K, Nagaya S, Mori Y, Deguchi K, Shiku H.
    Pol J Pharmacol; 1996 Jan 13; 48(2):225-8. PubMed ID: 9112656
    [Abstract] [Full Text] [Related]

  • 27. Thrombin activatable fibrinolysis inhibitor and other hemostatic parameters in patients with polycystic ovary syndrome.
    Oral B, Mermi B, Dilek M, Alanoğlu G, Sütçü R.
    Gynecol Endocrinol; 2009 Feb 13; 25(2):110-6. PubMed ID: 19253106
    [Abstract] [Full Text] [Related]

  • 28. Increased vascular endothelial cell markers in patients with disseminated intravascular coagulation.
    Wada H, Minamikawa K, Wakita Y, Nakase T, Kaneko T, Ohiwa M, Tamaki S, Deguchi K, Shirakawa S, Hayashi T.
    Am J Hematol; 1993 Oct 13; 44(2):85-8. PubMed ID: 8266924
    [Abstract] [Full Text] [Related]

  • 29. Posttrauma coagulation and fibrinolysis.
    Gando S, Tedo I, Kubota M.
    Crit Care Med; 1992 May 13; 20(5):594-600. PubMed ID: 1533358
    [Abstract] [Full Text] [Related]

  • 30. Evaluation the combined diagnostic value of TAT, PIC, tPAIC, and sTM in disseminated intravascular coagulation: A multi-center prospective observational study.
    Mei H, Jiang Y, Luo L, Huang R, Su L, Hou M, Wang X, Deng J, Hu Y.
    Thromb Res; 2019 Jan 13; 173():20-26. PubMed ID: 30458338
    [Abstract] [Full Text] [Related]

  • 31. Characterization of thrombin activatable fibrinolysis inhibitor in normal and acquired haemostatic dysfunction.
    Toh CH.
    Blood Coagul Fibrinolysis; 2003 Jun 13; 14 Suppl 1():S69-71. PubMed ID: 14567541
    [Abstract] [Full Text] [Related]

  • 32. Thrombin-activatable fibrinolysis inhibitor antigen and TAFI activity in patients with APC resistance caused by factor V Leiden mutation.
    Antovic JP, Blombäck M.
    Thromb Res; 2002 Apr 01; 106(1):59-62. PubMed ID: 12165290
    [Abstract] [Full Text] [Related]

  • 33. Plasma thrombin-activatable fibrinolysis inhibitor (TAFI) antigen levels in acromegaly patients in remission.
    Erdoğan M, Özbek M, Akbal E, Üreten K.
    Turk J Med Sci; 2019 Oct 24; 49(5):1381-1385. PubMed ID: 31549496
    [Abstract] [Full Text] [Related]

  • 34. Evaluation of haemostatic molecular markers for diagnosis of disseminated intravascular coagulation in patients with infections.
    Asakura H, Wada H, Okamoto K, Iba T, Uchiyama T, Eguchi Y, Kawasugi K, Koga S, Mayumi T, Koike K, Gando S.
    Thromb Haemost; 2006 Feb 24; 95(2):282-7. PubMed ID: 16493490
    [Abstract] [Full Text] [Related]

  • 35. Effect of levothyroxine suppression therapy on plasma thrombin activatable fibrinolysis inhibitor antigen levels in benign thyroid nodules.
    Akinci B, Demir T, Comlekci A, Yener S, Ozcan MA, Karaoglu O, Yuksel F, Secil M, Yesil S.
    Med Princ Pract; 2011 Feb 24; 20(1):23-8. PubMed ID: 21160209
    [Abstract] [Full Text] [Related]

  • 36. Significant correlations between tissue factor and thrombin markers in trauma and septic patients with disseminated intravascular coagulation.
    Gando S, Nanzaki S, Sasaki S, Kemmotsu O.
    Thromb Haemost; 1998 Jun 24; 79(6):1111-5. PubMed ID: 9657433
    [Abstract] [Full Text] [Related]

  • 37. Thrombin activatable fibrinolysis inhibitor (TAFI): a molecular link between coagulation and fibrinolysis.
    Miljić P, Heylen E, Willemse J, Djordjević V, Radojković D, Colović M, Elezović I, Hendriks D.
    Srp Arh Celok Lek; 2010 Jan 24; 138 Suppl 1():74-8. PubMed ID: 20229688
    [Abstract] [Full Text] [Related]

  • 38. Thrombin-activatable fibrinolysis inhibitor in young patients with myocardial infarction and its relationship with the fibrinolytic function and the protein C system.
    Zorio E, Castelló R, Falcó C, España F, Osa A, Almenar L, Aznar J, Estellés A.
    Br J Haematol; 2003 Sep 24; 122(6):958-65. PubMed ID: 12956767
    [Abstract] [Full Text] [Related]

  • 39. Thrombin-activatable fibrinolysis inhibitor deficiency in cirrhosis is not associated with increased plasma fibrinolysis.
    Lisman T, Leebeek FW, Mosnier LO, Bouma BN, Meijers JC, Janssen HL, Nieuwenhuis HK, De Groot PG.
    Gastroenterology; 2001 Jul 24; 121(1):131-9. PubMed ID: 11438502
    [Abstract] [Full Text] [Related]

  • 40. Plasma levels of activated protein C-protein C inhibitor complex in patients with hypercoagulable states.
    Watanabe R, Wada H, Sakakura M, Mori Y, Nakasaki T, Okugawa Y, Gabazza EC, Hayashi T, Nishioka J, Suzuki K, Shiku H, Nobori T.
    Am J Hematol; 2000 Sep 24; 65(1):35-40. PubMed ID: 10936861
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.